International Clinical Trial: Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07453888) titled 'Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)' on March 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).

Primary Sponsor: Dompe Farmaceutici S.p.A

Condition: Non-Arteritic Anterior Ischemic Optic Neuropathy

Intervention: Drug: Cenegermin

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: March 2026

Target Sample Size: 272

To know more, visit http...